Capital Royalty Invests in Royalty Bonds

In third quarter of 2008, Capital Royalty purchased more than $10 million of royalty bonds supported by the revenues of products used to treat the symptoms associated with overactive bladder. The up-front proceeds allowed the issuer to invest in clinical development programs while avoiding having to issue equity at an unfavorable share price.